Alarm Raised on Neglected Parasitic Killer In East Africa

Kala-azar, also known Visceral Leishmaniasis or Black Fever, is the second most deadly disease to malaria and is caused by sand bites. The body's internal organs are attacked and the disease proves fatal in about 95% of cases.

Across Kenya, Sudan, and Ethiopia, weak and feverish patients are being taken to hospitals, stricken by the parasitic killer.

The World Health Organisation (WHO) estimates that 50,000 to 90,000 people globally are infected each year.

The progress in controlling Kala-azar is threatened by an acute shortage of an important "second-line" medicine given to patients when the standard treatment does not work. Known as AmBisome, this anti-fungal treatment is used for vulnerable Kala-azar patients such as pregnant women or for severe cases, writes Monique Wasunna for The Conversation.


Medics at the MSF hospital in Lankien, in South Sudan's Jonglei State, treat patients for kala-azar (file photo).

AllAfrica publishes around 800 reports a day from more than 100 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.